Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Oric Pharmaceuticals Stock

Q: How to sell Oric Pharmaceuticals stock?

If you hold private company shares of Oric Pharmaceuticals - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Oric Pharmaceuticals stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

oricpharma.comHealthcare / BioTech & PharmaFounded: 2014Funding to Date: $173MM

ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer.

Buy or sell Oric Pharmaceuticals stockLearn more about Oric Pharmaceuticals IPO

OverviewFinancingsValuation

Enterprise Value

Access Oric Pharmaceuticals’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Oric Pharmaceuticals.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Jacob Chacko MD

Chief Executive Officer & Board Member

Charles Sawyers MD

Co-Founder

Dominic Piscitelli

Chief Financial Officer

Matthew Panuwat

Chief Business Officer

Lori Friedman Ph.D

Chief Scientific Officer

Richard Heyman Ph.D

Co-Founder, Chairman & Board Member

Scott Lowe Ph.D

Co-Founder

Board Members

Leo Guthart

Laurence Lasky Ph.D

Richard Scheller Ph.D

Carl Gordon Ph.D

OrbiMed

Richard Heyman Ph.D

Peter Svennilson

The Column Group

Jacob Chacko MD

Oric Pharmaceuticals stock FAQs

Can you buy Oric Pharmaceuticals stock?

As Oric Pharmaceuticals is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Oric Pharmaceuticals, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Oric Pharmaceuticals stock?

To invest in a private company like Oric Pharmaceuticals through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Oric Pharmaceuticals stock?

Yes, you may be able to sell your Oric Pharmaceuticals stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Oric Pharmaceuticals stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Oric Pharmaceuticals stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Oric Pharmaceuticals a public company?

No, Oric Pharmaceuticals is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Oric Pharmaceuticals’ stock price?

Oric Pharmaceuticals is a privately held company and therefore does not have a public stock price. However, you may access Oric Pharmaceuticals’ private market stock price with Forge Data.

What is Oric Pharmaceuticals’ stock ticker symbol?

Oric Pharmaceuticals does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Xconomy 04/24/2020

Xconomy: ORIC Pharma Gets $120M in IPO to Advance Drug-Resistant Cancer Therapies

ORIC Pharmaceuticals followed in the footsteps of the other biotechs that have managed to go public this month, selling more shares than it expected for a

PR Newswire 09/10/2019

ORIC Pharmaceuticals Appoints Dominic Piscitelli as Chief Financial Officer

/PRNewswire/ -- ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on developing cancer treatments that address mechanisms of...

Market Screener 08/08/2019

ORIC Pharmaceuticals : Announces Completion of $55 Million Mezzanine Financing to Advance Pipeline of Novel Therapies Targeting Cancer Resistance

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.